(thirdQuint)Efficacy and Safety of Tolvaptan in Japanese Patients With Acute Heart Failure.

 Vasopressin mediates fluid retention in heart failure.

 Tolvaptan, an oral, nonpeptide, selective vasopressin V2-receptor antagonist, shows promise for management of heart failure.

.

 Efficacy and Safety of Tolvaptan in Japanese Patients With Acute Heart Failure@highlight

The aims of the present study are to investigate prospectively the clinical course and outcome of the hospitalized heart failure patients treated with tolvaptan for management of fluid retention and serum sodium levels of less than 140 mEq/L and also to analyze the factors related with the efficacy including outcome of tolvaptan therapy.

